
There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …

The latest data from GW Pharma is about as conclusively positive as you can usually hope to get with a …

Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …

The US Court of Appeals for the Federal Circuit has judged that Johnson & Johnson’s patent for its best-selling arthritis …

The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …

NICE has said that a new online and mobile app should be trialled on the NHS in the treatment of …

Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all …

GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after …

In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …

Bristol-Myers Squibb has revealed that its immunotherapy Yervoy (ipilimumab) has received an expanded indication from the European Commission, approving the …

It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on …

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …

Biogen received marketing approval from the European Commission for Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA), in May …

Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 …

On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …

Liberal Democrat MP Norman Lamb has drawn attention to what he has called an “extraordinary scandal” in which an estimated …

Sanofi interest in making a big acquisition has been clear for the last few years and its struggles to solidify …

AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra (benralizumab) has been given authorisation …